Foghorn Therapeutics Inc. Common Stock FHTX

$4.92 +1.03% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-06 View →
8-K 8-K 2026-08-06 View →
4 PRIMARY DOCUMENT 2026-06-25 View →
4 PRIMARY DOCUMENT 2026-06-25 View →
4 PRIMARY DOCUMENT 2026-06-25 View →
4 PRIMARY DOCUMENT 2026-06-25 View →
4 PRIMARY DOCUMENT 2026-06-25 View →
4 PRIMARY DOCUMENT 2026-06-25 View →
4 PRIMARY DOCUMENT 2026-06-25 View →
4 PRIMARY DOCUMENT 2026-06-25 View →
4 PRIMARY DOCUMENT 2026-06-25 View →
8-K 8-K 2026-06-24 View →
10-Q 10-Q 2026-05-07 View →
8-K 8-K 2026-05-07 View →
DEF 14A DEF 14A 2026-04-30 View →
8-K 8-K 2026-04-21 View →
4 PRIMARY DOCUMENT 2026-04-13 View →
10-K 10-K 2026-03-11 View →
8-K 8-K 2026-03-11 View →
4 PRIMARY DOCUMENT 2026-02-24 View →
8-K 8-K 2026-02-23 View →
4 PRIMARY DOCUMENT 2026-02-06 View →
4 PRIMARY DOCUMENT 2026-02-02 View →
4 PRIMARY DOCUMENT 2026-02-02 View →
4 PRIMARY DOCUMENT 2026-02-02 View →
4 PRIMARY DOCUMENT 2026-02-02 View →
4 PRIMARY DOCUMENT 2026-02-02 View →
4 4 2026-01-15 View →
424B5 424B5 2026-01-12 View →
8-K 8-K 2026-01-12 View →
8-K 8-K 2025-12-04 View →
4 PRIMARY DOCUMENT 2025-11-17 View →
8-K 8-K 2025-11-07 View →
10-Q 10-Q 2025-11-05 View →
8-K 8-K 2025-11-05 View →
8-K 8-K 2025-10-30 View →
8-K 8-K 2025-09-02 View →
10-Q 10-Q 2025-08-05 View →
8-K 8-K 2025-08-05 View →
8-K 8-K 2025-07-01 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$4.92
Market Cap
$292.18 million
52-Week Range
$3.27 $7.61
Average Volume
332K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.